3,680 reports of this reaction
2.1% of all DIAZEPAM ORAL reports
#6 most reported adverse reaction
FATIGUE is the #6 most commonly reported adverse reaction for DIAZEPAM ORAL, manufactured by Chartwell Governmental & Specialty RX, LLC.. There are 3,680 FDA adverse event reports linking DIAZEPAM ORAL to FATIGUE. This represents approximately 2.1% of all 177,537 adverse event reports for this drug.
Patients taking DIAZEPAM ORAL who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for DIAZEPAM ORAL, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for DIAZEPAM ORAL:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 3,680 FDA reports for DIAZEPAM ORAL. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.1% of all adverse event reports for DIAZEPAM ORAL, making it a notable side effect.
If you experience fatigue while taking DIAZEPAM ORAL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.